Single subcutaneous dosing of cefovecin in rhesus monkeys (Macaca mulatta): A pharmacokinetic study

Journal of Veterinary Pharmacology and Therapeutics

Volumn 34, Issue 5, 2011, Pages 464-468

  Bakker, Jaco ^a   Thuesen, L R ^b   Braskamp, G ^a   Skaanild, M T ^b   Ouwerling, B ^a   Langermans, J A M ^a   Bertelsen, M F ^c  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c CENTER FOR ZOO AND WILD ANIMAL HEALTH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOVECIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD SAMPLING; CAT; DOG; DRUG EXCRETION; DRUG HALF LIFE; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; MACACA MULATTA; MALE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SINGLE DRUG DOSE; SKIN INFECTION; TIME TO MAXIMUM PLASMA CONCENTRATION; URINALYSIS; URINARY EXCRETION; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CEPHALOSPORINS; FEMALE; HALF-LIFE; INJECTIONS, SUBCUTANEOUS; MACACA MULATTA; MALE; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; MACACA MULATTA;

EID: 80052671828     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01265.x     Document Type: Article

References (20)

1. Bertelsen, M.F., Thuesen, L.R., Bakker, J., Hebel, C., Grondahl, C., Brimer, L. & Skaanild, M.T. (2010) Limitations and usages of cefovecin in zoological practice. In Proceedings of the International Conference on Diseases of Zoo and Wild Animals. Eds Wibbelt, G., Szentiks, C., Grobbel, M., Kretschmar, P. and Seet, S. pp. 140-141. Leibniz Institute for Zoo and Wildlife Research, Berlin.
2. Clingerman, K.J. & Summers, L. (2005) Development of a body condition scoring system for nonhuman primates using Macaca mulatta as a model. Lab Animal, 34, 31-36.
3. College voor zorgverzekeringen (2010a) Middelen bij wondbehandeling en desinfectie van de huid. In: Farmacotherapeutisch Kompas, Ed Sitsen, J.M.A., pp. 654-659. Dendrite, Naarden, The Netherlands.
4. College voor zorgverzekeringen (2010b) Cefalosporinen. In: Farmacotherapeutisch Kompas, Ed Sitsen, J.M.A., pp. 747-754. Dendrite, Naarden, The Netherlands.
5. Foord, R.D. (1976) Cefuroxime: Human Pharmacokinetics. Antimicrobial Agents and Chemotherapy, 9, 741-747.
6. García-Párraga, D., Gilabert, J.A., Valls, M., Ros-Rodríguez, J.M., Álvaro, T., Rojo-Solís, C. & Encinas, T. (2010a) Pharmacokinetics of Cefovecin (Convenia ™) after intramuscular administration to dolphins (Tursiops truncatus) and sea lion (Otaria flavescens). IAAAM 41st Annual Conference Proceedings 2010, 42-43.
7. García-Párraga, D., Ros-Rodríguez, J.M., Álvaro, T., Gilabert, J.A., Valls, M., Rojo-Solís, C., García-Moratalla, D. & Encinas, T. (2010b) Preliminary study of cefovecin (Convenia) pharmacokinetics in several aquatic species. EAAM 38th Symposium Proceedings.
8. Garton, A.M., Rennie, R.P., Gilpin, J., Marrelli, M. & Shafran, S.D. (1997) Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels. Journal of Antimicrobial Chemotherapy, 4, 903-906.
9. Howell-Jones, R.S., Wilson, M.J., Hill, K.E., Howard, A.J., Price, P.E. & Thomas, D.W. (2005) A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. Journal of Antimicrobial Chemotherapy, 55, 143-149.
10. Lilenbaum, W., Moraes, I.A., Cardoso, V.S., Varges, R.G., Ferreira, A.M.R. & Pissinatti, A. (2006) Antibiotic resistance in Staphylococci isolated from the vaginas of captive female Leontopithecus (Callitrichidae-Primates). American Journal of Primatology, 68, 825-831.
11. Montesinos, A., Diez- Delgado, I., Gilabert, J.A., Ardiaca, M., Ros-Rodriguez, J.M. & Encinas, T. (2010) Pharmacokinetics of cefovecin (Convenia ™) by subcutaneous route in ferrets (Mustela putorius furo). In: Proceedings of the International Conference on Diseases of Zoo and Wild Animals 2010, Eds Wibbelt, G., Szentiks, C., Grobbel, M., Kretschmar, P. and Seet, S. pp. 231-232. Leibniz Institute for Zoo and Wildlife Research, Berlin.
12. National Research Council (2003) Water. Nutrient Requirements of Nonhuman Primates, 2nd revised edn, pp. 150-158. The National Academies Press, Washington, DC.
13. Stegemann, M.R., Passmore, C.A., Sherington, J., Lindeman, C.J., Papp, G., Weigel, D.J. & Skogerboe, T.L. (2006a) Antimicrobial activity and spectrum of Cefovecin, a new extended-spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America. Antimicrobial Agents and Chemotherapy, 50, 2286-2292.
14. Stegemann, M.R., Sherington, J. & Blanchflower, S. (2006b) Pharmacokinetics and pharmacodynamics of cefovecin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 29, 501-511.
15. Stegemann, M.R., Sherington, J., Coati, N., Brown, S.A. & Blanchflower, S. (2006c) Pharmacokinetics of cefovecin in cats. Journal of Veterinary Pharmacology and Therapeutics, 29, 513-524.
16. Thuesen, L.R., Bertelsen, M.F., Brimer, L. & Skaanild, M.T. (2009) Selected pharmacokinetic parameters for cefovecin in hens and green iguanas. Journal of Veterinary Pharmacology and Therapeutics, 32, 613-617.
17. Toutain, P.L. & Bousquet-Mélou, A. (2004a) Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics, 27, 441-453.
18. Toutain, P.L. & Bousquet-Mélou, A. (2004b) Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics, 27, 415-425.
19. Verhagen, C.A., Mattie, H. & Van Strijen, E. (1994) The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion. British Journal of Clinical Pharmacology, 37, 193-197.
20. Welling, P.G., Dean, S., Selen, A., Kendall, M.J. & Wise, R. (1979) Probenecid: an unexplained effect on cephalosporin pharmacology. British Journal of Clinical Pharmacology, 8, 491-495.